Study Determines Preferred Attributes of PI Combination Therapies for R/R Multiple Myeloma Oncology Nurse Advisor , 21 Dec 2018 December 21, 2018 Oral administration, longer disease-free progression, and fewer AEs rank highest among preferred attributes…